Azathioprine is the most common drug used to maintain clinical remission in inflammatory bowel disease. This drug is also important as a steroid-sparing agent in steroid-dependent and chronically active inflammatory bowel disease. Nevertheless, many questions remain concerning the optimal treatment regimens of azathioprine. The dose of aza-thioprine has to be reduced or the therapy has to be discontinued frequently because of drug-induced toxicity. In this review, we discuss monitoring of thiopurines, adverse events, malignant complications and how to use azathio-prine safely and usefully. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 65∼70
Background: Previous studies have reported no or only a very poor correlation between 6-methylmercap...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
Azathioprine (AZA) is a well-known immunosuppressant used for many years for its ability to ensure l...
BACKGROUND: Early-onset inflammatory bowel disease (IBD) is generally aggressive, with a high proba...
Introduction. Thiopurines, such as azathioprine (AZA) and 6-mercaptopurine (6-MP), are immunomodulat...
Purpose: This study was aimed to evaluate the frequency and course of adverse events associated with...
Thiopurines, alone or in combination with other agents, have a pivotal role in the treatment of spec...
Low-dose azathioprine with allopurinol (LDAA) has been proposed as a potent therapy in inflammatory ...
Azathioprine and 6-mercaptopurine are effective drugs in the management of steroid dependent and chr...
Thiopurines are essential drugs to maintain remission in patients with inflammatory bowel disease (I...
Thiopurines have been widely used to maintain steroid-free remission in children with inflammatory b...
Inflammatory bowel disease is mainly caused by dysragulated immune system. Inflammatory bowel diseas...
Background: Previous studies have reported no or only a very poor correlation between 6-methylmercap...
Background: Thiopurines, such as azathioprine and mercaptopurine, are of pivotal importance in the t...
BACKGROUND: Low-dose azathioprine with allopurinol (LDAA) has been proposed as a potent therapy in i...
Background: Previous studies have reported no or only a very poor correlation between 6-methylmercap...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
Azathioprine (AZA) is a well-known immunosuppressant used for many years for its ability to ensure l...
BACKGROUND: Early-onset inflammatory bowel disease (IBD) is generally aggressive, with a high proba...
Introduction. Thiopurines, such as azathioprine (AZA) and 6-mercaptopurine (6-MP), are immunomodulat...
Purpose: This study was aimed to evaluate the frequency and course of adverse events associated with...
Thiopurines, alone or in combination with other agents, have a pivotal role in the treatment of spec...
Low-dose azathioprine with allopurinol (LDAA) has been proposed as a potent therapy in inflammatory ...
Azathioprine and 6-mercaptopurine are effective drugs in the management of steroid dependent and chr...
Thiopurines are essential drugs to maintain remission in patients with inflammatory bowel disease (I...
Thiopurines have been widely used to maintain steroid-free remission in children with inflammatory b...
Inflammatory bowel disease is mainly caused by dysragulated immune system. Inflammatory bowel diseas...
Background: Previous studies have reported no or only a very poor correlation between 6-methylmercap...
Background: Thiopurines, such as azathioprine and mercaptopurine, are of pivotal importance in the t...
BACKGROUND: Low-dose azathioprine with allopurinol (LDAA) has been proposed as a potent therapy in i...
Background: Previous studies have reported no or only a very poor correlation between 6-methylmercap...
Background: Azathioprine therapy is discontinued in one-third of patients with inflammatory bowel di...
Azathioprine (AZA) is a well-known immunosuppressant used for many years for its ability to ensure l...